Highlights Hainan Poly Pharm. Co., Ltd

Equities

300630

CNE100002N10

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
8.21 ^CNY	-2.84%		+3.40%	-63.70%

Jul. 05	Hainan Poly Pharm. Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Jul. 01	Hainan Poly Pharm's Gets Certification for Invasive Aspergillosis Drug	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hainan Poly Pharm. Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Jul. 05	CI
Hainan Poly Pharm's Gets Certification for Invasive Aspergillosis Drug	Jul. 01	MT
Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Denmark	Jun. 25	MT
Hainan Poly Pharm's Unit Gets Nod to Market Raw Drug Ingredient Gadoterate Gluconamide	Jun. 06	MT
Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Sweden	Apr. 08	MT
Hainan Poly Pharm Gets Nod to Market Skin Infection Drug in Germany	Apr. 04	MT
Hainan Poly Pharm's Brivaracetam Injection Gets FDA's Nod to Enter US Market; Shares Up 3%	Mar. 04	MT
Hainan Poly Pharm Gets Nod to Market Pantoprazole Sodium for Injection in Singapore	Dec. 12	MT
Hainan Poly Pharm. Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Hainan Poly Pharm's Gets US FDA Nod to Market Iopamidol Injection	23-10-09	MT
Tranche Update on Hainan Poly Pharm. Co., Ltd's Equity Buyback Plan announced on April 25, 2023.	23-09-15	CI
Hainan Poly Pharm. Co., Ltd's Equity Buyback announced on April 25, 2023 has closed with 1,426,700 shares, representing 0.33% for CNY 30.03 million.	23-09-13	CI
Hainan Poly Pharm's Unit Passes US FDA's On-Site Inspection	23-09-11	MT
Hainan Poly Pharm. Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Hainan Poly Pharm's Unit Passes Regulator's GMP Inspection	23-08-07	MT
Hainan Poly Pharm. Co., Ltd Announces Dividend Implementation of Cash Dividend for 2022, Payable on 18 July 2023	23-07-11	CI
Tranche Update on Hainan Poly Pharm. Co., Ltd's Equity Buyback Plan announced on April 25, 2023.	23-07-03	CI
Hainan Poly Pharm. Co.,Ltd Approves Cash Dividend for 2022	23-05-24	CI
Hainan Poly Pharm Gets Regulatory OK to Convert Desloratadine Dispersible Tablets into Over-The-Counter Drugs	23-05-04	MT
Hainan Poly Pharm. Co.,Ltd Proposes Final Profit Distribution for 2022	23-04-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hainan Poly Pharm. Co., Ltd

Equities

300630

CNE100002N10

Highlights

Filters